echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Mercayon applied to FDA to expand the HPV vaccine Gardasil to prevent pharynx cancer in both men and women

    Mercayon applied to FDA to expand the HPV vaccine Gardasil to prevent pharynx cancer in both men and women

    • Last Update: 2020-06-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    MSD applied to U.Sregulators to expand the human papillomavirus (HPV) vaccine Gardasil's indications topreventionof oral and other throat cancers and other head and neck cancers caused by type 16, 18, 31, 33, 45, 52 and 58 HPVThe company noted that the indications were approved in accordance with Gardasil's effectiveness in preventing HPV-related genital diseases, adding that the expansion of indications may depend on the results of clinical studies in validation trials, which are currently under waywomen in men and women are likely to develop HPV-induced oral cancer, but men are five times more likely to develop oral cancer than womenthe disease may have been caused by aof HPVinfection in the mouth, according to a new model released by the Center for Human ItyIn terms of disease control and prevention (CDC), it has overtaken cervical cancer as the most common HPV-related cancer in the countryGardasil has been approved for the prevention of HPV-induced cervical, vulwant, vaginal,, oral and other head and neck cancers, as well as pre- or hyperploilous lesions of genital warts and cancersin men, the vaccine prevents, oral and other head and neck cancers caused by HPV, as well as pre- or hyperplhenosis of genital warts and cancers
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.